SCHEMBL4878265

SCHEMBL4878265

COc1cccc(C2(C(=O)OS(N)(=O)=O)CCC(O)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
STS P08842 2/20 0.41
ADAM17 P78536 1/20 0.41
KDM1A O60341 1/20 0.41
SLC6A4 P31645 3/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A3 Q01959 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD11B1 P28845 1/20 0.38
SLC22A1 O15245 1/20 0.38
OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4877607 0.87 SIGMAR1 (0.42) ALDH1A1STSADAM17KDM1ASLC6A4
SCHEMBL4880364 0.87 HDAC4 (0.41) ALDH1A1STSADAM17KDM1ASLC6A4
SCHEMBL4872683 0.85 ADAM17 (0.52) ALDH1A1ADAM17KDM1ASLC6A4SLC6A2
SCHEMBL4880472 0.85 STS (0.42) ALDH1A1STSADAM17KDM1ACA12
SCHEMBL4877674 0.84 MEN1 (0.41) ALDH1A1ADAM17MEN1KMT2ACA12
SCHEMBL4876712 0.83 OPRD1 (0.46) ALDH1A1STSMEN1KMT2ACA12
SCHEMBL4874919 0.82 L3MBTL1 (0.39) ALDH1A1ADAM17MEN1KMT2ACA12
SCHEMBL4880541 0.81 SOAT1 (0.48) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL4876701 0.79 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL4878256 0.79 ALDH1A1 (0.43) ALDH1A1ADAM17KDM1ASLC6A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 ALDH1A1 2899/4885STS 68/4885ADAM17 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.